References

BD MAX™ MRSA Assay [package insert]. (2022). BD Diagnostics. https://static.bd.com/documents/eifu/P0205.pdf

Biomerieux. Biofire^® Covid-19 test. (2021). https://www.fda.gov/media/136353/download

Bonetta, L. (2005). Prime time for real-time PCR. Nature Methods. 2:305-312. https://www.nature.com/nmeth/journal/v2/n4/full/nmeth0405-305.html

Boughton, B. (2009). Universal PCR Screening for MRSA may cut costs, reduce infection. Medscape Medical News. https://www.medscape.com/viewarticle/708813

Cepheid. Xpert^® (2019). C. difficile package insert. https://www.cepheid.com/Package%20Insert%20Files/Xpert%20C.difficile%20ENGLISH%20Package%20Insert%20300-8023%20Rev.%20G.pdf

Cepheid. Xpert^® Xpress SARS-CoV-2 package insert. (2022). https://www.cepheid.com/content/dam/www-cepheid-com/documents/package-insert-files/xpress-sars-cov-2/Xpert%20Xpress%20SARS-CoV-2%20Assay%20ENGLISH%20Package%20Insert%20302-3562%20Rev.%20G.pdf

Desjardins, M., Guibord, C., Lalonde, B., Toye, B., & Ramotar, K. (2006). Evaluation of the IDI-MRSA Assay for the detection of methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in selective broth. Journal of Clinical Microbiology. 44(4):1219-1223. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448652/

Dhamad, A., & Abdal, R. (2020). COVID-19: Molecular and serological detection methods. Peer J. 8:e10180. doi:10.7717/peerj.10180

Eastwood, K., Else, P., Charlett, A., & Wilcox, M. (2009). Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. Journal of Clinical Microbiology. 47(10):3211-3217. doi:10.1128/JCM.01082-09

Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus ---United States (2009). Morbidity and Mortality Weekly Report. 58(30):826-829. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5830a2.htm

Farley, J., Stamper, P., Ross, T., Cai, M., Speser, S., & Carroll, K. (2008). Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population. Journal of Clinical Microbiology. 46(2):743-746. doi:10.1128/JCM.02071-07

Forrest, G., Mehta, S., Weeks, E., Lincalis, D., Johnson, J., & Venezia, R. (2006). Impact of rapid in situ hybridization testing on coagulase negative staphylocci positive blood cultures. J Antimicrob Chemother. 58(1):154-158. https://jac.oxfordjournals.org/content/58/1/154.full

Interim guidance for influenza surveillance: Prioritizing RT-PCR testing in laboratories. (2009). Centers for Disease Control and Prevention. https://archive.cdc.gov/www_cdc_gov/h1n1flu/screening.htm

Interim guidance for the detection of novel influenza a virus using rapid influenza diagnostic tests. (2009). Centers for Disease Control and Prevention. http://med.iiab.me/modules/en-cdc/www.cdc.gov/h1n1flu/guidance/rapid_testing.htm

Leber, A. & Burnham, C. (2023). Clinical Microbiology Procedures Handbook. (5th ed.). ASM Press

Lieberman, J., Pepper, G., Naccache, S., Huang, M., Jerome, K., & Greninger, A. (2020). Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. Journal of Clinical Microbiology. 58(8):e00821-20. doi:10.1128/JCM.00821-20

Persing, D. (2016). Molecular Microbiology: Diagnostic Principles and Practice. (3rd ed.). ASM Press

Pfaller, M. (2001). Molecular approaches to diagnosing and managing infectious diseases: practicality and costs. Emerging Infectious Diseases. https://wwwnc.cdc.gov/eid/article/7/2/70-0312_article.htm

Rossney, A., Herra, C., Brennan, G., Morgan. P., & O'Connell, B. (2008). Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert Real-Time PCR platform for rapid detection of MRSA from screening specimens. Journal of Clinical Microbiology. 46(10):3285-3290. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566096/

Serajian, S., Ahmadpour, E., Oliveira, S., Pereira, M., & Heidarzadeh, S. (2021). CRISPR-Cas Technology: Emerging applications in clinical microbiology and infectious diseases. Pharmaceuticals (Basel). 14(11):1171. doi:10.3390/ph14111171

Tenover, F., Tickler, I., Le, V., Dewell, S., Mendes, R., & Goering, R. (2019). Updating molecular diagnostics for detecting methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates in blood culture bottles. Journal of Clinical Microbiology. 57(11):e01195-19. doi:10.1128/JCM.01195-19

The 2009 H1N1 Pandemic: Summary Highlights, April 2009–April 2010. (2010). Centers for Disease Control and Prevention. https://archive.cdc.gov/www_cdc_gov/h1n1flu/cdcresponse.htm